Atopic dermatitis and the metabolic syndrome: a cross-sectional study of 116 816 patients.

Abstract

Data regarding the association between atopic dermatitis (AD) and the metabolic syndrome are controversial. To evaluate the prevalence of the metabolic syndrome and its components in a large group of patients with AD compared to a matched reference group. A cross-sectional study of AD patients diagnosed by a dermatologist between 1998 and 2016, and a matched comparison group was performed. We analysed the association between AD and metabolic syndrome, its components and possible complications for the entire study population, adults (age>18) and adults with moderate-to-severe AD. The study included 116816 patients with AD and 116812 comparison enrollees. AD in the entire group of patients and in the adult patients was associated with a higher prevalence of dyslipidaemia and a lower prevalence of diabetes and metabolic syndrome. Moderate and severe AD were associated, respectively, with higher prevalence rates of the metabolic syndrome (17.0% vs. 9.4%), its components (obesity: 22.2% vs. 18.6%; diabetes: 15.9% vs. 9.2%; hypertension 27.9% vs. 15.3%; dyslipidaemia 47.1% vs. 28.5%, all P values<0.001) and cardiovascular morbidity (all P values<0.001). Multivariate analysis demonstrated a significant overrepresentation of the metabolic syndrome in moderate-to-severe AD (P=0.04). Severely affected patients with AD may have one or more undiagnosed components of metabolic syndrome.